A pilot randomized trial of automatic, artificial intelligence-based vs manual, electronic medical record-based remote postpartum blood pressure monitoring - 22/08/24
Doi : 10.1016/j.ajog.2024.06.008
Adam K. Lewkowitz, MD, MPHS 
Department of Obstetrics and Gynecology, Warren Alpert Medical School at Brown University, Providence, RI
Center for Digital Health, Brown School of Public Health, Providence, RI
Rackeem Baker, BA
Department of Obstetrics and Gynecology, Warren Alpert Medical School at Brown University, Providence, RI
Lauren E. Schlichting, PhD
Hassenfeld Child Health Innovation Institute, Brown School of Public Health, Providence, RI
Crystal F. Ware, BSN, CCRP, Janet Rousseau, BSN
Department of Obstetrics and Gynecology, Warren Alpert Medical School at Brown University, Providence, RI
Emily S. Miller, MD, MPH
Department of Obstetrics and Gynecology, Warren Alpert Medical School at Brown University, Providence, RI
Hassenfeld Child Health Innovation Institute, Brown School of Public Health, Providence, RI
Alisse Hauspurg, MD, MS
Department of Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh, PA
Dwight J. Rouse, MD
Department of Obstetrics and Gynecology, Warren Alpert Medical School at Brown University, Providence, RI
Caroline Richardson, MD
Department of Family Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island
Methodius G. Tuuli, MD, MPH
Department of Obstetrics and Gynecology, Warren Alpert Medical School at Brown University, Providence, RI
Video |
(7.48 Mo)
Plan
| A.K.L. has served on a medical advisory board for Pharmacosmos Therapeutics, Incorporated in 2022 and on a medical advisory board for Shields Pharmaceuticals in 2021. R.B., L.E.S., C.F.W., J.R., E.S.M., A.H., D.J.R., C.R., R.G., and M.G.T. report no conflict of interest. |
|
| A.K.L. is supported by the NICHD (K23HD103961). A.H. is supported by the NHLBI (K23HL168356). This study was also supported by a grant from the CVS Foundation/Essential Hospitals Institute. These funding sources had no role in study design, collection, analysis, or interpretation of the data, or in the decision to submit the article for publication. |
|
| Clinical Trials information: i) Date of submission: October, 21, 2022; ii) Date of First participant enrollment: November 7, 2022; iii) Clinical trial identification number: NCT 05595629; iv) URL: NCT05595629; v) Data sharing: not yet published but will do so once primary manuscript is accepted. |
|
| A secondary analysis of this randomized trial was presented at SMFM's Annual Pregnancy Conference from Feb., 10–14, 2024. |
© 2024
Elsevier Inc. Tous droits réservés.
Vol 231 - N° 3
P. 358 - septembre 2024 Retour au numéro
Article précédent
- Prenatal methamphetamine use increases risk of adverse maternal and neonatal outcomes
- Sarena Hayer, Bharti Garg, Jessica Wallace, Kristin C. Prewitt, Jamie O. Lo, Aaron B. Caughey
- The relation between low-grade fever during prolonged rupture of membranes (>12 hours) at term and infectious outcomes: a retrospective cohort study
- Raneen Abu Shqara, Yara Nakhleh Francis, Lior Lowenstein, Maya Frank Wolf
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?